NCT04037228

Brief Summary

Osteoarthritis (OA) is a very common condition in the elderly population. Treatment for end-stage OA is total knee Replacement (TKR)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 30, 2019

Completed
9 months until next milestone

Study Start

First participant enrolled

April 30, 2020

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 7, 2023

Status Verified

December 1, 2023

Enrollment Period

4.7 years

First QC Date

June 20, 2019

Last Update Submit

December 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes of Radiological Assessments of the knees at baseline

    Standing antero-posterior (AP) hip-knee-ankle (HKA) and lateral knee-to-ankle radiographs will be performed to determine the varus/valgus alignment and the posterior slope of the tibial components relative to the mechanical axis.

    Through study completion, an average of 1 year

  • Changes of Radiological Assessments of the knees post-operatively

    Standing antero-posterior (AP) hip-knee-ankle (HKA) and lateral knee-to-ankle radiographs will be performed to determine the varus/valgus alignment and the posterior slope of the tibial components relative to the mechanical axis.

    Through study completion, an average of 1 year

Secondary Outcomes (1)

  • Knee Functions measure by the Knee Society Score

    Through study completion, an average of 1 year

Study Arms (1)

KneeAlign 2

Those of the group will be adopt KneeAlign 2: accelerometer-based navigation system at total knee arthroplasty.

Device: KneeAlign 2 system (OrthAlign Inc, Aliso Viejo, California)

Interventions

The KneeAlign 2 system (OrthAlign Inc, Aliso Viejo, California) is an accelerometer-based, portable navigation device for TKA that attempts to combine the alignment accuracy of large-console CAS systems, with the ease of use and convenience of conventional alignment methods. It is used to perform the proximal tibial and distal femoral resections in TKA. It consists of a disposable display console (2 × 4 × 2 inches in size) and a reference sensor, both of which are used for the tibial and femoral resections The display console and reference sensor each contains triaxial accelerometers that communicate wirelessly with one another. Briefly, the tibial jig has 2 primary components (a fixed component and a mobile component) connected by a proximal articulation .The fixed component, with the attached reference sensor, is first pinned to the tibia. The purpose of the fixed component is to account for the movement of the tibia during cutting block alignment.

KneeAlign 2

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Osteoarthritis knee patients in hospital

You may qualify if:

  • Male and female subjects aged over 18 years old
  • All patients must provide their written consent
  • patients with a history of osteoarthritis, rheumatoid arthritis, or post-traumatic arthritis who will receive a primary, posterior-stabilized TKA.
  • All patients should have at least 8 years of school education;
  • Radiological evidence of osteoarthritis with Kellgren and Lawrence grade 2 or above

You may not qualify if:

  • Patients are planned to receive a unicondylar or patellofemoral arthroplasty.
  • Patients with previous cases of alcoholism or drug abuse;
  • Pregnancy and breast-feeding;
  • Presence of serious pathologies;
  • revision surgery
  • Knee infection
  • Non-consenting patients who have not provided the written Informed Consent;
  • Mechanical instability, ligamentous laxity/deficiency and gross deformity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopaedics & Traumatology

Hong Kong, Hong Kong

RECRUITING

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professional Consultant

Study Record Dates

First Submitted

June 20, 2019

First Posted

July 30, 2019

Study Start

April 30, 2020

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

December 7, 2023

Record last verified: 2023-12

Locations